Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma: The phase III "PREVENT" trial of the AIO /CAOGI /ACO.

被引：0

作者：

Goetze, Thorsten Oliver

Piso, Pompiliu

Lorenzen, Sylvie

Bankstahl, Ulli Simone

Ostrzyzek, Marcin

Pauligk, Claudia

Habibzade, Timursah

Reim, Daniel

Bechstein, Wolf Otto

Konigsrainer, Alfred

Monig, Stefan Paul

Rau, Beate

Schwarzbach, Matthias

Al-Batran, Salah-Eddin

机构：

[1] Univ Canc Ctr Frankfurt, Inst Klin Onkol Forsch, Frankfurt, Germany

[2] Univ Canc Ctr Frankfurt, Inst Klin Krebsforschung IKF GmbH Krankenhaus Nor, Frankfurt, Germany

[3] Univ Regensburg, Dept Gen & Visceral Surg, Hosp Barmherzige Brueder, Regensburg, Germany

[4] Tech Univ Muenchen, Dept Internal Med Hematol Med Oncol 3, Klinikum Rechts Isar, Munich, Germany

[5] Univ Canc Ctr Frankfurt, Inst KlinischOnkol Forsch Krankenhaus Nordwest, Frankfurt, Germany

[6] Inst Klin Krebsforschung IKF GmbH Krankenhaus Nor, Frankfurt, Germany

[7] Inst Clin Canc Res IKF GmbH, Krankenhaus Nordwest, Frankfurt, Germany

[8] UCT Univ Canc Ctr, Inst Clin Canc Res, Krankenhaus Nordwest, Frankfurt, Germany

[9] Tech Univ Munchen, Klin & Poliklinik Chirurg, Klinikum Rechts Isar, Munich, Germany

[10] Univ Hosp Frankfurt, Dept Gen & Visceral Surg, Frankfurt, Germany

[11] Univ Hosp Tuebingen, Dept Gen Visceral & Transplantat, Tubingen, Germany

[12] Univ Hosp Geneva, Geneva, Switzerland

[13] Charite Campus Mitte Univ Berlin, Berlin, Germany

[14] Klinikum Frankfurt Hochst, Dept Gen Visceral Vasc & Thorac Surg, Frankfurt, Germany

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.TPS4149

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS4149

引用

页数：3